PT - JOURNAL ARTICLE AU - Abigail G. Schindler AU - Britahny Baskin AU - Barbara Juarez AU - Suhjung Janet Lee AU - Rebecca Hendrickson AU - Katherine Pagulayan AU - Larry S. Zweifel AU - Murray A. Raskind AU - Paul E.M. Phillips AU - Elaine R. Peskind AU - David G. Cook TI - Repetitive but not single blast mild traumatic brain injury increases ethanol responsivity in mice and risky drinking behavior in combat Veterans AID - 10.1101/2020.11.10.20229427 DP - 2020 Jan 01 TA - medRxiv PG - 2020.11.10.20229427 4099 - http://medrxiv.org/content/early/2020/11/13/2020.11.10.20229427.short 4100 - http://medrxiv.org/content/early/2020/11/13/2020.11.10.20229427.full AB - Mild traumatic brain injury (mTBI) is common in civilians and highly prevalent among military Servicemembers and in contact sports athletes. mTBI, especially within military populations, is often comorbid with posttraumatic stress disorder (PTSD), and can increase health-risk behaviors (e.g., sensation/novelty seeking, impulsivity, risk taking, irritability/aggression) and substance misuse/abuse, but underlying mechanisms remain poorly understood. Using an established mouse model of blast mTBI, here we examined the effects of single (1x) and repetitive (3x) blast exposure on ethanol responsivity using a battery of tests, each associated with distinct aspects of alcohol abuse vulnerability. While both single and repetitive blast exposure increased the sedative properties of high-dose ethanol (with no change in tolerance or metabolism), only repetitive blast exposure potentiated ethanol-induced locomotor stimulation and shifted ethanol intake patterns (i.e., increased consumption ‘front-loading’) during intermittent two bottle choice. To establish translational relevance, we next examined self-report responses to the Alcohol Use Disorders Identification Test-Consumption Questions (AUDIT-C) and used a novel unsupervised machine learning approach to investigate whether a history of blast with acute symptoms and mTBI affected drinking behaviors in Iraq and Afghanistan Veterans. AUDIT-C scores were increased in Veterans with a history of blast exposure and subsequent cluster analysis identified a three-cluster solution: ‘low’ (low intake and low frequency), ‘frequent’ (low intake but high frequency), and ‘risky’ (high intake and high frequency), where Veterans with a history of blast mTBI displayed a shift in cluster assignment from ‘frequent’ to ‘risky’, as compared to Veterans who were deployed to Iraq and/or Afghanistan who had no lifetime history of TBI. Together, these results offer new insight regarding how blast mTBI may give rise to increased substance use/misuse and highlight the increased potential for adverse health-risk behaviors following repetitive blast mTBI exposure.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAcknowledgments: This work was supported by a Department of Veteran Affairs (VA) Basic Laboratory Research and Development (BLR&D) Career Development Award 1IK2BX003258 (AGS), VA Clinical Sciences Research and Development (CSR&D) Career Development Award IK2CX001774 (RCH), a VA BLR&D Merit Review Award 5I01BX002311 (DGC), VA Rehabilitation Research and Development Service Merit Review Award #B77421 (ERP), University of Washington Friends of Alzheimer's Research (DGC, ERP), UW Royalty Research Fund (DGC), the VA Northwest Mental Illness Research Education and Clinical Center (MAR, ERP, RCH), and the Burroughs Wellcome Fund Postdoctoral Enrichment Program grant #1019873 (BJ).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:VA Puget Sound IRB approvedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailable upon request.